Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




High-Throughput Product Technologies Focus on Flexibility and Efficiency

By Labmedica staff writers
Posted on 11 Feb 2008
Several high-throughput product technologies and a new consultative approach to optimizing laboratory automation that focus on improving labs' application flexibility, efficiency, and robustness have been launched. More...
The new products include a multiplate reader, high-throughput microplates, and monochromator and cellular screening platforms.

Filter-based and monochromator-based platforms have been integrated into the established EnVision microplate-reader product line. The dual-system platform enables scientists to choose their high-throughput detection method, and provides faster assay turnaround. The new monochromator option is available in two formats: the Absorbance Monochromator measures absorbance assays with a single monochromator, while the Fluorescence Intensity Monochromator measures absorbance and fluorescence intensity with a high performance quad monochromator package. The monochromator option is part of a highly flexible instrument system. It can be combined with other EnVision options, including the time-resolved fluorescence (TRF) laser; can easily be integrated into robotic systems; and can accept microplates with up to 3,456 wells.

The new LumiLux cellular screening (CS) platform is an ultra-high throughput cellular imaging platform for both kinetic flash and glow luminescence assays with advanced liquid handling functionality. An instrument with walk-away capability, it provides sensitive detection using patented fiberoptic imaging technology, state-of-the-art liquid handling, and sophisticated data analysis tools. In addition LumiLux introduces a unique cell stirrer that permits the use of both suspension and adherent cells in ultra (u)HTS screens.

The new platform has a compact design that preserves the performance and sensitivity of the current LumiLux platform. It has a much smaller footprint that meets the increased demand of high-throughput screening (HTS) labs, switching lower throughput applications or integration into new or existing robotic platforms for HTS. The LumiLux platforms enable simultaneous 1,536 "inject and read” flash luminescence assays, allowing laboratories to produce over 200,000 data points per day. It is particularly well suited for uHTS calcium screening

PerkinElmer (Waltham, MA, USA) introduced the new instrumentation as well as an enhanced consultation approach at LabAutomation 2008, which took place from January 27-30, 2008, at Palm Springs (CA, USA). PerkinElmer Inc.'s Life and Analytical Sciences business unit provides fully integrated solutions such as diagnostic and detection instruments, reagents, and software.


Related Links:
PerkinElmer

Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Laboratory Software
ArtelWare
Gold Member
Hybrid Pipette
SWITCH
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.